MENU

Nanotherapeutics: An insight into healthcare and future multi-dimensional clinical applications

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Research Affiliate, Integrative Behavioural Health Research Institute
    Biography
      Pratibha Kakadia received her PhD in Pharmaceutical Science from University of Huddersfield, England, UK. Her graduate research was completed in the lab of Prof. Barbara Conway, Ph.D. Her research is focussed on the investigation of design and development of nanoformulations for the targeted delivery of antibacterial drugs for treatment of skin infections. She has worked as Scientist in Merck Research Labs in Pennsylvania, supporting formulation of RNA based lipid nanoparticles delivery for preclinical research. Currently, Pratibha is the Research Affiliate with Integrative Behavioural Health Research Institute, Pasadena, California. She has three-first author publications in the reputed peer-reviewed journals and 2 oral and 10 poster talks on the design and formulation of lipid nanoparticles approach for controlled and targeted drug delivery.

    Abstract

    In recent years Nanotherapeutics has revolutionized the healthcare strategies and envisioned to have a tremendous impact to offer better health facilities. It involves design, fabrication, regulation, and application of therapeutic drugs and devices having a size in nano-range (1–100 nm). Owing to the revolutionary implications in drug delivery and gene therapy, lipid nanoparticles has gained increasing research interest in the current medical sector of the modern world. Current clinical efforts are focused on vaccination, protein replacement therapies, and treatment of genetic diseases. Since the first pre-clinical studies in the 1990s, significant progress in the clinical translation of mRNA therapeutics has been made through advances in the design of mRNA manufacturing and intracellular delivery methods. The growth of such powerful biologic therapeutics has gone hand in hand with the progress in delivery systems technology, which is absolutely required to improve their safety and effectiveness.

    One of the most developed methods for RNA delivery is co-formulation into lipid nanoparticles (LNP). LNP as drug delivery vehicles is becoming more attractive because it can pack drug product more efficiently, enhance its bioavailability, and target specific cells. In this presentation, we discuss the revolution of lipid nanoparticles into precision medicine and recent advances in biomaterials and drug delivery strategies, challenges for clinical translations of RNA based therapeutics with an overview of the future clinical applications in protein therapy, gene editing, and vaccination.

    Learning Objectives:

    1. What current Nanomedicine are being developed for drug delivery

    2. Why use lipid nanoparticles for RNA delivery

    3. Recent advances and clinical applications


    Show Resources
    You May Also Like
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources